Lumbar Disc Disease
0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
BioRestorative TherapiesBRTX-100
Spinal ElementsKarma Posterior Fixation Device
Globus MedicalExcelsiusGPS™
Clinical Trials (3)
Total enrollment: 319 patients across 3 trials
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Start: Jun 2022Est. completion: Dec 202799 patients
Phase 2Recruiting
Study of the Long-Term Outcomes of Posterior Spinal Fixation With the Karma Device
Start: Aug 2021Est. completion: Jun 202520 patients
N/ACompleted
Prospective Robotic Global Research Study (PROGRESS)
Start: Dec 2019Est. completion: Dec 2021200 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 319 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.